Biotechnology News and Research

RSS

Senesco's multiple myeloma drug candidate data to be presented at the AACR-NCI-EORTC conference

Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference.

12 Nov 2009

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has announced that two of its studies regarding its application in oncology drug development and personalized medicine have been selected for a poster and oral presentation at the upcoming AACR-EORTC conference in Boston.

12 Nov 2009

Third-quarter 2009 results announced by Neurologix

Neurologix, Inc., a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the third quarter ended September 30, 2009.

12 Nov 2009

LAB Research announces financial results for the third quarter of 2009

LAB Research Inc., a global Canadian-based non-clinical contract research organization, today announced its 2009 third quarter financial results.

12 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

Pacific Biosciences selects Camstar Manufacturing enterprise software to deliver innovative products

Camstar Systems, Inc. announced today that Pacific Biosciences, a leader in the development of a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform, has selected the Camstar Manufacturing™ enterprise software platform to enable its critical transition from product development to high-volume production, and to ensure consistent top product quality.

12 Nov 2009

New biopharmaceutical business intelligence tool from Deloitte Recap

Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.

11 Nov 2009

UK research funders announce support for a series of H1N1 2009 research projects

Leading UK research funders today announce -7.5 million of funding for a series of projects aimed at understanding the development and spread of pandemic influenza H1N1 2009 - or 'swine flu'. The research will look at every aspect of the virus, on pig farms, in pig and human populations, and in hospital intensive care units.

11 Nov 2009

Vertex Pharmaceuticals announces exchange agreement with holders of its 4.75% Convertible Senior Subordinated Notes

Vertex Pharmaceuticals Incorporated announced today that holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal amount of those notes and accrued interest for approximately 4.8 million shares of the Company’s common stock, which is approximately 140,000 shares more than the number of shares into which the notes were convertible under their original terms.

11 Nov 2009

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

11 Nov 2009

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

11 Nov 2009

UIC receives federal grant to develop new antibiotics against anthrax, tularemia and plague

Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague.

11 Nov 2009

Teva Pharmaceutical's generic lansoprazole does not infringe patent No. 5,464,632: U.S. Court

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Takeda Pharmaceuticals North America, Inc.'s Prevacid® (Lansoprazole) SoluTab.

10 Nov 2009

Life Technologies to acquire BioTrove

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

10 Nov 2009

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Scarab Genomics has made a series of planned, precise deletions to the E. coli K-12 genome, reducing the genome by more than 15%. The multiple-deletion series (MDS™) strains eliminate non-essential genes, cryptic virulence genes, and sequences of recombinogenic and mobile insertion sequence (IS) DNA, while preserving robust growth in rich and minimal media.

10 Nov 2009

Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.

10 Nov 2009

Biotechnology News and Research

Senesco's multiple myeloma drug candidate data to be presented at the AACR-NCI-EORTC conference

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Third-quarter 2009 results announced by Neurologix

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

LAB Research announces financial results for the third quarter of 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Pacific Biosciences selects Camstar Manufacturing enterprise software to deliver innovative products

New biopharmaceutical business intelligence tool from Deloitte Recap

UK research funders announce support for a series of H1N1 2009 research projects

Vertex Pharmaceuticals announces exchange agreement with holders of its 4.75% Convertible Senior Subordinated Notes

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

UIC receives federal grant to develop new antibiotics against anthrax, tularemia and plague

Teva Pharmaceutical's generic lansoprazole does not infringe patent No. 5,464,632: U.S. Court

Life Technologies to acquire BioTrove

Aduro BioTech raises funds through its Series A-1 financing

BioVex completes $70M financing to complete OncoVEX Phase III study

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market

Biotechnology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News